← Back

Wire · opportunities

Functional Precision Medicine: The New Precision Oncology?

Published

6 August 2026

Topic

opportunities

Sectors

Biotech

Geography

United States

Source

Read at cancer.gov

Verified

Fusion42 · 6 August 2026 · Fusion42 review

Functional precision medicine tests living cancer cells directly with therapies to identify effective treatments for individual cancer patients, aiming to complement genomic precision medicine and expand personalized oncology. Recent advances and workshop discussions highlight the need for clinical evidence, standardised procedures, and regulatory adaptation to integrate this approach into routine care.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ The Wire takeaway

You face a window to lead cancer treatment beyond gene sequencing by embracing live cell drug testing methods in your pipeline. Standardisation and regulatory cooperation are opening, making it time to align your lab and clinical efforts on functional precision medicine before this approach becomes mainstream.

Coverage

1 source · 6 Aug 2026

Related on Wire

Topics

Biotechprecision-oncologyfunctional-medicinecancer-treatmentregulatory-adaptationclinical-evidence